Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent applications of quantitative systems pharmacology and machine learning models across diseases
Sara Sadat Aghamiri, Rada Amin, Tomáš Helikar
Journal of Pharmacokinetics and Pharmacodynamics (2021) Vol. 49, Iss. 1, pp. 19-37
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing
Ethan A. Poweleit, Alexander A. Vinks, Tomoyuki Mizuno
Therapeutic Drug Monitoring (2023) Vol. 45, Iss. 2, pp. 143-150
Open Access | Times Cited: 47
Two heads are better than one: current landscape of integrating QSP and machine learning
Tongli Zhang, Ioannis P. Androulakis, Peter L. Bonate, et al.
Journal of Pharmacokinetics and Pharmacodynamics (2022) Vol. 49, Iss. 1, pp. 5-18
Open Access | Times Cited: 40
Strategies of Artificial intelligence tools in the domain of nanomedicine
Mohammad Habeeb, Huay Woon You, Mutheeswaran Umapathi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105157-105157
Closed Access | Times Cited: 26
Artificial intelligence-driven drug development against autoimmune diseases
Philippe Moingeon
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 411-424
Open Access | Times Cited: 24
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
Yurong Qin, Miaozhe Huo, Xingwu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Computational approaches to modelling and optimizing cancer treatment
Thomas O. McDonald, Yu-Chen Cheng, Christopher Graser, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 10, pp. 695-711
Closed Access | Times Cited: 21
Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition
Hanwen Wang, Theinmozhi Arulraj, Holly Kimko, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 17
Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology
Theinmozhi Arulraj, Hanwen Wang, Alberto Ippolito, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 6
Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupus
Vincent Hurez, Glenn Gauderat, Perrine Soret, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111754-111754
Open Access
An introduction to quantitative systems pharmacology for chemical engineers
R. Abbiati, César Pichardo‐Almarza
Physical Sciences Reviews (2025)
Closed Access
Using machine learning surrogate modeling for faster QSP VP cohort generation
Renée C. Myers, Florian Augustin, Jérémy Huard, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 8, pp. 1047-1059
Open Access | Times Cited: 9
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity
Stefano Zoroddu, Paola Corona, Luca Sanna, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114440-114440
Closed Access | Times Cited: 13
New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools
Lily Arrué, Alexandra Cigna-Méndez, Tábata Barbosa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1914-1914
Open Access | Times Cited: 11
Quantitative systems modeling approaches towards model-informed drug development: Perspective through case studies
Meghna Verma, Louis Gall, Jacopo Biasetti, et al.
Frontiers in Systems Biology (2023) Vol. 2
Open Access | Times Cited: 6
DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challenges
Akihiko Goto, Yuu Moriya, Miyu Nakayama, et al.
Drug Metabolism and Pharmacokinetics (2024) Vol. 56, pp. 101003-101003
Open Access | Times Cited: 1
Practical QSP application from the preclinical phase to enhance the probability of clinical success: Insights from case studies in oncology
Masayo Oishi, Hiroyuki Sayama, Kota Toshimoto, et al.
Drug Metabolism and Pharmacokinetics (2024) Vol. 56, pp. 101020-101020
Closed Access | Times Cited: 1
A quantitative systems pharmacology model of plasma kallikrein-kinin system dysregulation in hereditary angioedema
Dan Sexton, Hoa Nguyen, Salomé Juethner, et al.
Journal of Pharmacokinetics and Pharmacodynamics (2024) Vol. 51, Iss. 6, pp. 721-734
Open Access | Times Cited: 1
Life scientists improve QSP model quality and impact
Katherine Kudrycki, Christina Friedrich, Mike Reed, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial
Hongtao Yu, Peter J. Greasley, Hiddo J. Lambers Heerspink, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 22, pp. 4693-4707
Open Access | Times Cited: 1
Exploring Scoring Function Space: Developing Computational Models for Drug Discovery
Gabriela Bitencourt‐Ferreira, Marcos A. Villarreal, Rodrigo Quiroga, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 17, pp. 2361-2377
Closed Access | Times Cited: 3
Machine learning studies for liquid crystal texture recognition
Natalia Osiecka, Anna Drzewicz, Ewa Juszyńska‐Gałązka
Liquid Crystals (2023) Vol. 51, Iss. 2, pp. 255-264
Closed Access | Times Cited: 3
Use of Artificial Intelligence to Identify New Mechanisms and Approaches to Therapy of Bone Disorders Associated With Chronic Kidney Disease
Adam E. Gawęda, Eleanor D. Lederer, Michael E. Brier
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 5
Quantitative Systems Pharmacology: A Foundation To Establish Precision Medicine–Editorial
Annabelle Ballesta, James M. Gallo
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 387, Iss. 1, pp. 27-30
Open Access | Times Cited: 2
Editorial: Model-informed drug development and evidence-based translational pharmacology
Jinxin Zhao, Xiao Zhu, Songwen Tan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Understanding the Benefits of Deep Learning in Drug Discovery: A Scoping Review
Masibulele Msayi, Lumka Thami. P Salamntu
(2024), pp. 168-173
Closed Access
Page 1 - Next Page

Scroll to top